preview

Genicon Case Summary

Decent Essays

Genicon is a firm with ten years of domestic experience and some actual global success. Genicon was successful in America, but it quickly understood that it would be hard for them to have viable growth, because the health care buys medical equipment through GPOs. As a small firm it was tough to obtain a contract from GPOs since their financial arrangement encouraged them to buy equipment from big companies. Consequently, Genicon decided to go global and catch growing demand there. It became the smallest firm to sell products to European clients with the assistance of BSI. Genicon is already in over thirty international markets and is looking in particular at the rapidly emerging markets - Brazil, Russia, India and China - as potential new opportunities …show more content…

With an importance on maintaining a trade surplus, China has heavy defiance towards foreign imports. Moreover, there is a rising trend of preference towards domestic Chinese countries over foreign companies. For instance, General Order No.95 released by the government needs all medical devices imported into China to go through severe safety inspections. However, the same requirements are not applied to Chinese-made products. Firms wishing to introduce new products into the market have to face significant governmental pressure and wait for typically 12 months to have a new piece of equipment permitted. Similarly, the state in Russia is also quite disapproving. In addition to a great degree of bureaucracy, possible changes to legislation that sought to assist the domestic producers instead of foreign firms are likely to take place. In contrast, import of medical equipment has been progressively growing in India, and is consistently to have steady growth in the following years. The level of import defiance in Brazil is the lowermost midst the four countries as Brazil is greatly dependent on import of medical devices. Unlike the other three markets, import tariffs are low, and there are no import duties or value-added taxes on 42 medical devices. In addition, the product …show more content…

The simplicity of doing business index evaluates the influence of direct policies disturbing businesses in a particular nation. According to the index, China was ranked the 89th out of 185 countries, whereas Russia, Brazil and India were graded the 120th, the 129th, and the 133rd, respectively. Therefore, China is the best option amongst the four in terms of providing a stable business environment. However, there are two significant drawbacks surrounding the Chinese regulatory framework that would critically concern GENICON. Firstly, the country has a track record of not protecting foreign intellectual property rights. As the knowledge base for the medical devices that GENICON are carrying is readily available, local manufacturers can effortlessly start manufacturing nearly indistinguishable products and sell them at lower prices. Second, policy implementation in China is often escorted with deflection, as implementation measures are carried out in unpredictable and contradictory manners. Unavoidably, the uncertainty around the regulatory system creates additional legal risks. As exhibit 3 shows, the corruption perceptions score ratifies the lack of transparency within the Chinese legal structure. According to transparency international index, China scored 3.6 out of 10 and was ranked the 79th,

Get Access